Véronique Garambois

1.0k total citations
32 papers, 775 citations indexed

About

Véronique Garambois is a scholar working on Oncology, Radiology, Nuclear Medicine and Imaging and Molecular Biology. According to data from OpenAlex, Véronique Garambois has authored 32 papers receiving a total of 775 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Oncology, 15 papers in Radiology, Nuclear Medicine and Imaging and 13 papers in Molecular Biology. Recurrent topics in Véronique Garambois's work include Monoclonal and Polyclonal Antibodies Research (13 papers), HER2/EGFR in Cancer Research (10 papers) and Glycosylation and Glycoproteins Research (6 papers). Véronique Garambois is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (13 papers), HER2/EGFR in Cancer Research (10 papers) and Glycosylation and Glycoproteins Research (6 papers). Véronique Garambois collaborates with scholars based in France, United States and Switzerland. Véronique Garambois's co-authors include André Pèlegrin, Marta Jarlier, Isabelle Navarro‐Teulon, Julie Pannequin, Jean‐François Bourgaux, Dominique Joubert, Frédéric Hollande, Charbel Darido, Michael Büchert and Jean‐Pierre Pouget and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and PLoS ONE.

In The Last Decade

Véronique Garambois

30 papers receiving 766 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Véronique Garambois France	15	306	296	274	162	109	32	775
Ziren Kong China	18	231 0.8×	185 0.6×	381 1.4×	188 1.2×	100 0.9×	47	878
Almuth F. Keßler Germany	16	209 0.7×	203 0.7×	129 0.5×	101 0.6×	88 0.8×	57	704
Jose Carrillo United States	12	212 0.7×	176 0.6×	249 0.9×	225 1.4×	50 0.5×	41	795
Corina Taitt United States	7	659 2.2×	230 0.8×	134 0.5×	324 2.0×	106 1.0×	14	1.2k
Shannon Chang United States	14	196 0.6×	281 0.9×	174 0.6×	248 1.5×	66 0.6×	37	928
David P. Kodack United States	10	474 1.5×	354 1.2×	111 0.4×	441 2.7×	137 1.3×	13	1.0k
Karin Staflin United States	13	182 0.6×	264 0.9×	123 0.4×	72 0.4×	56 0.5×	17	576
Rikke Hedegaard Dahlrot Denmark	18	266 0.9×	443 1.5×	104 0.4×	180 1.1×	68 0.6×	60	1.1k
Kiek Verrijp Netherlands	12	195 0.6×	380 1.3×	92 0.3×	138 0.9×	41 0.4×	15	774
Tim Cloughesy United States	9	191 0.6×	267 0.9×	138 0.5×	176 1.1×	57 0.5×	17	758

Countries citing papers authored by Véronique Garambois

Since Specialization

Citations

This map shows the geographic impact of Véronique Garambois's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Véronique Garambois with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Véronique Garambois more than expected).

Fields of papers citing papers by Véronique Garambois

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Véronique Garambois. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Véronique Garambois. The network helps show where Véronique Garambois may publish in the future.

Co-authorship network of co-authors of Véronique Garambois

This figure shows the co-authorship network connecting the top 25 collaborators of Véronique Garambois. A scholar is included among the top collaborators of Véronique Garambois based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Véronique Garambois. Véronique Garambois is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Vezzio-Vié, Nadia, Antoine Aze, Hervé Seitz, et al.. (2025). TopBP1 biomolecular condensates as a new therapeutic target in advanced-stage colorectal cancer. eLife. 14.

Vié, Nadia, et al.. (2025). Shining light on drug discovery: optogenetic screening for TopBP1 biomolecular condensate inhibitors. NAR Cancer. 7(4). zcaf041–zcaf041.

Garambois, Véronique, Augusto Faria Andrade, Marta Jarlier, et al.. (2023). Improving the response to oxaliplatin by targeting chemotherapy-induced CLDN1 in resistant metastatic colorectal cancer cells. Cell & Bioscience. 13(1). 72–72. 12 indexed citations

Garambois, Véronique, Christel Larbouret, Laurie Lajoie, et al.. (2023). Design and selection of optimal ErbB-targeting bispecific antibodies in pancreatic cancer. Frontiers in Immunology. 14. 1168444–1168444. 6 indexed citations

Garambois, Véronique, Nelly Pirot, Charles Theillet, et al.. (2021). Anti-tumoral activity of the Pan-HER (Sym013) antibody mixture in gemcitabine-resistant pancreatic cancer models. mAbs. 13(1). 1914883–1914883. 7 indexed citations

Chauvin, Maëva, Véronique Garambois, Pierre‐Emmanuel Colombo, et al.. (2021). Anti-Müllerian hormone (AMH) autocrine signaling promotes survival and proliferation of ovarian cancer cells. Scientific Reports. 11(1). 2231–2231. 10 indexed citations

Garambois, Véronique, Nadège Gaborit, Christel Larbouret, et al.. (2020). Biasing human epidermal growth factor receptor 4 (HER4) tyrosine kinase signaling with antibodies: Induction of cell death by antibody‐dependent HER4 intracellular domain trafficking. Cancer Science. 111(7). 2508–2525. 3 indexed citations

Fraisse, Julien, Marta Jarlier, Florence Boissière‐Michot, et al.. (2020). Higher Anti-Tumor Efficacy of the Dual HER3-EGFR Antibody MEHD7945a Combined with Ionizing Irradiation in Cervical Cancer Cells. International Journal of Radiation Oncology*Biology*Physics. 106(5). 1039–1051. 8 indexed citations

Andrade, Augusto Faria, Diégo Tosi, Henri‐Alexandre Michaud, et al.. (2019). Inhibition of Ataxia-Telangiectasia Mutated and RAD3-Related ( ATR ) Overcomes Oxaliplatin Resistance and Promotes Antitumor Immunity in Colorectal Cancer. Cancer Research. 79(11). 2933–2946. 49 indexed citations

10.

Clorennec, Christophe Le, Hervé Bazin, Olivier Dubreuil, et al.. (2017). Neuregulin 1 Allosterically Enhances the Antitumor Effects of the Noncompeting Anti-HER3 Antibody 9F7-F11 by Increasing Its Binding to HER3. Molecular Cancer Therapeutics. 16(7). 1312–1323. 13 indexed citations

11.

Gutowski, Marian, Bérénice Framery, Martin C. Boonstra, et al.. (2017). SGM-101: An innovative near-infrared dye-antibody conjugate that targets CEA for fluorescence-guided surgery. Surgical Oncology. 26(2). 153–162. 78 indexed citations

12.

Jacquet, Alexandra, Nathalie Kersual, Véronique Garambois, et al.. (2012). Abstract 2528: 3C23K: an anti-human Mullerian inhibiting substance type II receptor humanized monoclonal antibody for ovarian cancer targeted therapy. Cancer Research. 72(8_Supplement). 2528–2528. 2 indexed citations

13.

Ladjemi, Maha Zohra, Thierry Chardès, Stéphanie Corgnac, et al.. (2011). Vaccination with human anti-trastuzumab anti-idiotype scFv reverses HER2 immunological tolerance and induces tumor immunity in MMTV.f.huHER2(Fo5) mice. Breast Cancer Research. 13(1). R17–R17. 16 indexed citations

14.

Büchert, Michael, Caroline Bonnans, Charbel Darido, et al.. (2010). Symplekin promotes tumorigenicity by up-regulating claudin-2 expression. Proceedings of the National Academy of Sciences. 107(6). 2628–2633. 66 indexed citations

15.

Santoro, Lore, Véronique Garambois, Caroline Mollévi, et al.. (2009). Noninternalizing Monoclonal Antibodies Are Suitable Candidates for ¹²⁵I Radioimmunotherapy of Small-Volume Peritoneal Carcinomatosis. Journal of Nuclear Medicine. 50(12). 2033–2041. 50 indexed citations

16.

Darido, Charbel, Michael Büchert, Julie Pannequin, et al.. (2008). Defective Claudin-7 Regulation by Tcf-4 and Sox-9 Disrupts the Polarity and Increases the Tumorigenicity of Colorectal Cancer Cells. Cancer Research. 68(11). 4258–4268. 103 indexed citations

17.

Garambois, Véronique, Elodie Foulquier, Marc Ychou, et al.. (2004). Fully human IgG and IgM antibodies directed against the carcinoembryonic antigen (CEA) Gold 4 epitope and designed for radioimmunotherapy (RIT) of colorectal cancers. BMC Cancer. 4(1). 75–75. 14 indexed citations

18.

Azria, D., Christel Larbouret, Véronique Garambois, et al.. (2004). A bispecific antibody to enhance radiotherapy by tumor necrosis factor-α in human CEA–expressing digestive tumors. International Journal of Radiation Oncology*Biology*Physics. 58(2). 580–588. 8 indexed citations

19.

Dorvillius, Mylène, Véronique Garambois, Réjean Langlois, et al.. (2001). Internalisation enhances photo-induced cytotoxicity of monoclonal antibody-phthalocyanine conjugates. British Journal of Cancer. 85(11). 1787–1793. 45 indexed citations

20.

Garambois, Véronique, Marc Ychou, Bruno Robert, et al.. (1999). Involvement of circulating CEA in liver metastases from colorectal cancers re-examined in a new experimental model. British Journal of Cancer. 80(9). 1373–1379. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact